CAPTRUST Financial Advisors’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-1,302
Closed -$19K – 2917
2022
Q2
$19K Buy
1,302
+1,212
+1,347% +$20.7K ﹤0.01% 3403
2022
Q1
$2K Buy
90
+73
+429% +$2.07K ﹤0.01% 4489
2021
Q4
$1K Buy
+17
New +$775 ﹤0.01% 4573
2021
Q3
– Sell
-1,010
Closed -$56K – 4685
2021
Q2
$56K Sell
1,010
-325
-24% -$17.3K ﹤0.01% 2442
2021
Q1
$62K Buy
+1,335
New +$64.7K ﹤0.01% 2284

Other funds holding HCAT

CAPTRUST Financial Advisors's HCAT Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Health Catalyst (HCAT) in Q3 2022, closing a stake of 1,302 shares — an estimated $19K sold.

CAPTRUST Financial Advisors first reported a position in HCAT in Q1 2021 and held it in 5 quarters. The position peaked at $62K in Q1 2021. 171 funds tracked by Wall St. Rank hold HCAT as of Q3 2022.

  • CAPTRUST Financial Advisors reported no remaining Health Catalyst position as of Q3 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 1,302 Health Catalyst shares in Q3 2022, an estimated $19K.
  • CAPTRUST Financial Advisors first reported a position in Health Catalyst in Q1 2021 and held it in 5 quarters.
  • CAPTRUST Financial Advisors's Health Catalyst position peaked at $62K in Q1 2021.
  • 171 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.